Differential lethal effect of cytotoxic agents on proliferating and nonproliferating lymphoid cells.
D000818:Animals; D000917:Antibody Formation; D000970:Antineoplastic Agents / Q000494:pharmacology*; D001402:B-Lymphocytes / Q000187:drug effects* / Q000528:radiation effects; D002455:Cell Division / Q000187:drug effects*; D003520:Cyclophosphamide / Q000494:pharmacology; D003561:Cytarabine / Q000494:pharmacology; D003609:Dactinomycin / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004912:Erythrocytes / Q000276:immunology; D005472:Fluorouracil / Q000494:pharmacology; D006462:Hemolytic Plaque Technique; D008297:Male; D008727:Methotrexate / Q000494:pharmacology; D051379:Mice; D008806:Mice, Inbred AKR; D009588:Nitrogen Mustard Compounds / Q000494:pharmacology; D011830:Radiation Effects; D012756:Sheep / Q000276:immunology; D014750:Vincristine / Q000494:pharmacology
D000970:Antineoplastic Agents; D009588:Nitrogen Mustard Compounds; D003561:Cytarabine; D003609:Dactinomycin; D014750:Vincristine; D003520:Cyclophosphamide; D005472:Fluorouracil; D008727:Methotrexate